Kezar Life Sciences has become the latest biotech to decide that it could do better than a buyout offer from Concentra Biosciences. Concentra’s parent company Tang Capital Partners has a track ...

(RTTNews) - Kezar Life Sciences (KZR) announced that its Board has rejected the unsolicited, non-binding proposal from Concentra Biosciences, to acquire all of the outstanding shares of common ...

In a report released yesterday, David S Macdonald from Truist Financial maintained a Buy rating on Concentra Group Holdings Parent, Inc. (CON – Research Report), with a price target of $29.00.

Earlier on Thursday, Kezar Life Sciences rejected the previously disclosed unsolicited, non-binding proposal from Concentra Biosciences for cash consideration of $1.10 per share, plus a contingent ...

At the heart of SwitchBot is its Hub ecosystem, though. The SwitchBot Hub Mini is a great place to start, now including Matter support. HomeKit Weekly is a series focused on smart home accessories ...

Pinewood Studios has set plans to launch what it has described as a dedicated production hub to support filmmakers in the UK who are taking advantage of the UK’s newly introduced Independent ...

Happy Saturday! Gen Z is redefining yet another term, and this time, it's "lavender marriage." A phrase once reserved for the LGBTQ+ community is now being used to describe young people who are ...

Today, the Genolier Innovation Hub officially opened within the BioAlps Health Valley, marking a significant milestone for the Swiss, and global health and life sciences industries. The Hub has ...

The most notable change is to the company’s logo: what was previously a sans-serif wordmark styled as “Moz://a” has been updated to correctly spell out the Mozilla name, featuring a new ...

1 Day CON 0.52% DJIA 0.09% S&P Mid Cap 400 0.01% Health Care/Life Sciences 0.22% ...